The healthcare investor conference, scheduled for May 20 and 21 at the Willis Tower in Chicago, combines panel discussions, networking opportunities, and a startup pitch contest. Register today! The post Who is Speaking at INVEST 2025? appeared first on MedCity News.
Prices for brand-name drugs in the U.S. are three times what the same drugs cost in other countries. And in a recent KFF survey, 3 in 10 adults reported not taking their medicine as prescribed at some point in the past year because of costs. “An Arm and a Leg” is collecting stories from listeners…
HAVANA, Fla. — For a rural community, this town of 1,750 people has been more fortunate than most. A family doctor has practiced here for the last 30 years. But that ended in December when Mark Newberry retired. To attract a new doctor, Havana leaders took out want ads in local newspapers, posted notices on…
What is Guillain-Barre Syndrome (GBS)? Guillain-Barre Syndrome (GBS) is a rare but serious autoimmune disorder in which the body’s immune system mistakenly attacks the peripheral nervous system. It can cause muscle weakness, numbness, tingling, and even paralysis in severe cases. Although most patients recover, it can be life-threatening if the breathing muscles or autonomic functions…
George Boghos is CEO of Imagine Pediatrics, a company founded out of former CMS Innovation head Adam Boehler’s Rubicon Partners fund. Imagine is a wraparound tech-based service helping some of the sickest kids in America–think kids on feeding tubes, cancer, mental health conditions, autism and more. They provide telehealth and on the ground services (like…
In 2011, National Institutes of Health (NIH)-funded discoveries contributed $69 billion to the nation’s gross domestic product (GDP) and supported seven million jobs. In 2020 alone, the US biomedical and pharmaceutical private sector generated more than $1.4 trillion in economic output. From Reece et al. (Health Affairs 2025) In addition to economic output, private-sector R&D…
The answer to this question depends, not only on how well AI tools work, but also on how AI technologies are regulated by the FDA. Scott Gottlieb has some thoughts on preferred regulatory approaches in his recent article in JAMA Health Forum. Artificial intelligence tools with advanced analytical capabilities used in clinical practice, especially tools…
AI-powered documentation tools have proven successful in alleviating clinicians’ administrative burden and burnout. As these tools continue to evolve, healthcare leaders want to see more tech that can help surface the right data at the right time, as well as tools that can help speed up billing processes. The post AI Scribes Have Proven Their…
CEO Jim Rechtin says investing in primary-care expansion remains a priority, albeit one that’s playing second fiddle to fixing the profitability of the company’s core insurance operations.
Senators John Kennedy (R-Louisiana) and Eric Schmitt (R-Missouri) introduced a bill last week that would require “able-bodied adults” without dependents to work or volunteer for at least 20 hours per week to receive Medicaid benefits. The post Senators Introduce Bill that would Add Work Requirements for Medicaid appeared first on MedCity News.